Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusion
- 1 December 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (20) , 1464-1468
- https://doi.org/10.1016/0002-9149(90)90535-9
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- TRIAL OF LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE VERSUS ANTICOAGULANTS FOR PREVENTION OF AORTOCORONARY VEIN GRAFT OCCLUSIONThe Lancet, 1989
- Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass graftsThe Journal of Thoracic and Cardiovascular Surgery, 1985
- Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.Circulation, 1985
- Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusionEuropean Heart Journal, 1985
- Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.Heart, 1985
- IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)The Lancet, 1984
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsNew England Journal of Medicine, 1984
- Aspirin to Prevent Arterial ThrombosisNew England Journal of Medicine, 1982
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Noninvasive radioisotopic technique for detection of platelet deposition in coronary artery bypass grafts in dogs and its reduction with platelet inhibitors.Circulation, 1979